Vijaya Diagnostic Centre Limited (VIJAYA): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Vijaya Diagnostic Centre Limited, explained in plain English.

• ▪Vijaya Diagnostic Centre Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪VIJAYA closed at ₹1,464.20 on 29 October 2026.
• ▪Over the past year the shares are up 45.4%, trading between ₹848.00 and ₹1,593.60.
• ▪Reported fundamentals show a net margin of 21.87%, debt to equity of 44.15.
• ▪Our transparent MaxGrade checklist scores it B (66/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 32.8% with a maximum drawdown of -20.24% and a beta of 0.53 against NIFTY 50.
• ▪Recent coverage: Kaynes Technology among 3 stocks showing White Marubozu pattern
• ▪Recent coverage: Is India’s diagnostics sector poised for a long-term growth upswing? Axis Securities sees opportunity in three stocks

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.